BioCentury
ARTICLE | Company News

Aderis, Schwarz Pharma deal

July 25, 2005 7:00 AM UTC

Schwarz paid Aderis $67 million in cash to remove the royalties and milestones related to Neupro rotigotine that Schwarz would have owed Aderis. In 1998, Schwarz acquired worldwide rights to the dop...